emodin and glycogen
emodin has been researched along with glycogen in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Eger, K; Gaunitz, F; Gebhardt, R; Götschel, F; Günther, R; Hecht, A; Hofmann, HJ; Kolander, J; Lerche, KS; Teich, L; Zellmer, S | 1 |
Other Studies
1 other study(ies) available for emodin and glycogen
| Article | Year |
|---|---|
4-Aminoethylamino-emodin--a novel potent inhibitor of GSK-3beta--acts as an insulin-sensitizer avoiding downstream effects of activated beta-catenin.
Topics: Animals; Axin Protein; beta Catenin; Casein Kinase II; Cell Death; Cell Survival; Cells, Cultured; Cytoskeletal Proteins; Emodin; Fatty Acids; Glycogen; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hepatocytes; Humans; Inhibitory Concentration 50; Insulin; Mice; Models, Biological; Models, Molecular; Protein Kinase Inhibitors; Protein Stability; Rats; TCF Transcription Factors; Transcription, Genetic | 2010 |